The Madras High Court clarified the interpretation of Section 3c regarding patent eligibility of monoclonal antibodies in India. The Court held that synthetic antibodies may be patentable if they demonstrate novelty or technical advancement.
Read more about Monoclonal antibodies and Patents – How the Madras High Court interpreted Section 3(c)Authors, Copyright and Royalty Share : The Calcutta High Court gives clarity
The Calcutta High Court has clarified the scope of authors’ royalty rights under Indian copyright law, affirming protections introduced by the 2012 amendment. The judgment ensures that authors of literary and musical works receive royalties, irrespective of copyright ownership transfers or the date of creation.
Read more about Authors, Copyright and Royalty Share : The Calcutta High Court gives clarityAll set for VOMISET : Court restores trademark and allows renewal beyond deadline
The Bombay High Court restored Indi Pharma’s VOMISET trademark, permitting late renewal due to non-receipt of statutory notice. The order clarifies rights under Section 25(3) of the Trade Marks Act, 1999, and mandates timely Registrar action on such applications.
Read more about All set for VOMISET : Court restores trademark and allows renewal beyond deadlineCourt criticizes Patent Office for using outdated CRI Guidelines
The Madras High Court condemned the Patent Office’s reliance on outdated CRI guidelines in Microsoft’s patent application case, highlighting the significance of technical effect in computer related inventions. The court allowed the appeal and directed a new evaluation.
Read more about Court criticizes Patent Office for using outdated CRI GuidelinesNote on the WIPO Treaty on Intellectual Property, Genetic Resources, and Associated Traditional Knowledge
The WIPO Treaty on Intellectual Property, Genetic Resources, and Associated Traditional Knowledge seeks to enhance transparency and fairness in the patent system. It establishes disclosure requirements and safeguards for genetic resources and traditional knowledge within international intellectual property law.
Read more about Note on the WIPO Treaty on Intellectual Property, Genetic Resources, and Associated Traditional KnowledgeVictory for Novozymes: Madras High Court Overrules Patent Office’s Refusal
The Madras High Court has reversed the Patent Office’s rejection of Novozymes’ patent for enzyme granules in animal feed, emphasizing the need for detailed reasoning in refusal orders. The decision clarifies the application of inventive step and Section 3d in Indian patent law.
Read more about Victory for Novozymes: Madras High Court Overrules Patent Office’s RefusalCourt says infringing brand ‘Double Kabooter’ Jaa Jaa Jaa
The Delhi High Court ordered the cancellation of the DOUBLE KABOOTER trademark, citing prior use and deceptive similarity with DABAL KABUTER BRAND. This case highlights the importance of accurate trademark claims and evidence in Indian law.
Read more about Court says infringing brand ‘Double Kabooter’ Jaa Jaa JaaSnack Wars: Haldiram’s Battle for Brand Supremacy
This post explores Haldiram’s successful legal action against trademark infringement, resulting in permanent injunctions and damages. It discusses the judicial recognition of Haldiram as a well-known mark, reflecting broader implications for brand protection in India.
Read more about Snack Wars: Haldiram’s Battle for Brand SupremacyLost in the Inbox? Delhi High Court Saves Dabur’s Trademark Application
The Delhi High Court restored Dabur’s trademark application for Odonil Mystic Rose, citing procedural lapses by the Trade Marks Registry in serving the notice of opposition. The judgment reinforces the importance of fair opportunity and natural justice in trademark proceedings.
Read more about Lost in the Inbox? Delhi High Court Saves Dabur’s Trademark ApplicationCancerous Battle: Novartis and NATCO clash over Eltrombopag
The Delhi High Court Division Bench set aside an injunction against Natco Pharma in the Novartis Eltrombopag patent dispute. The judgment provides key guidance on patent validity challenges and the requirements under Section 3(d) of the Patents Act in pharmaceutical cases.
Read more about Cancerous Battle: Novartis and NATCO clash over Eltrombopag